UNSPSC 51303303: Ravuconazole

This classification denotes an antifungal agent with the molecular formula C22H17F2N5OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95YH599JWV, chemically known as bms-207,147 but generally known as ravuconazole, which bears US NIH Compound Identifier 467825. The term RAVUCONAZOLE is an International Non-Proprietary Name. Most nations schedule ravuconazole under HS 29341000 and SITC 51579. As of Q4 2014, RAVUCONAZOLE remains the US FDA Preferred Term for this commodity.

Ravuconazole bears US NLM identifiers UMLS ID C0535186 and NCI Concept Code C38688. SMILES: CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)O.

UNSPSC 51303303 Ravuconazole, a Commodity code, reflects state and local procurement of antifungal pharmaceutical products for medical and emergency-response use. Recent solicitation activity shows state and local bodies purchasing ravuconazole and related medical supplies as components of broader first-aid and emergency-medical inventory replenishment, typically bundled with antiseptic agents, pain relievers, and bandaging materials rather than as standalone pharmaceutical line items. Issuing bodies under this code include municipal fire and rescue departments procuring medical aid supplies for field operations and emergency response. The City of Tampa Fire Rescue Department represents the type of repeating buyer in this space—municipal emergency-response agencies that maintain rotating inventories of medical consumables and require periodic competitive bidding to replenish stock.

The City of Tampa Fire Rescue Department posted Invitation to Bid 25P00157 on April 24, 2026, for medical aid supplies including antifungal and related pharmaceutical products, with a response deadline of April 9, 2025 and a total departmental budget of $100,000. The solicitation covers 32 medical and first aid supply items with estimated annual quantities ranging from 1 to 2,700 units per item, and includes set-aside provisions offering a 5% bid discount for City-certified Small Local Business Enterprises (SLBEs) with discounts capped at $10,000 and for Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) with discounts capped at $20,000. Awards are anticipated for an initial one-year term with potential for two additional one-year renewals. All medications must meet a minimum nine-month expiration date from acceptance, and the City reserves the right to award by aggregate total or individual line items.